Diet- and microbiota-related metabolite, 5-aminovaleric acid betaine (5-AVAB), in health and disease

Trends Endocrinol Metab. 2022 Jul;33(7):463-480. doi: 10.1016/j.tem.2022.04.004. Epub 2022 May 2.

Abstract

5-Aminovaleric acid betaine (5-AVAB) is a trimethylated compound associated with the gut microbiota, potentially produced endogenously, and related to the dietary intake of certain foods such as whole grains. 5-AVAB accumulates within the metabolically active tissues and has been typically found in higher concentrations in the heart, muscle, and brown adipose tissue. Furthermore, 5-AVAB has been associated with positive health effects such as fetal brain development, insulin secretion, and reduced cancer risk. However, it also has been linked with some negative health outcomes such as cardiovascular disease and fatty liver disease. At the cellular level, 5-AVAB can influence cellular energy metabolism by reducing β-oxidation of fatty acids. This review will focus on the metabolic role of 5-AVAB with respect to both physiology and pathology. Moreover, the analytics and origin of 5-AVAB and related compounds will be reviewed.

Keywords: 5-aminovaleric acid betaine (5-AVAB); N,N,N-trimethyl-5-aminovalerate (TMAV); N,N,N-trimethyl-5-aminovaleric acid (TMAVA); aminovaleric acid betaine; δ-valerobetaine (δVB).

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids, Neutral*
  • Betaine / metabolism
  • Diet
  • Gastrointestinal Microbiome*
  • Humans

Substances

  • Amino Acids, Neutral
  • Betaine
  • 5-aminovaleric acid